NO20035748D0 - Optisk avbildning av sårbar arteriosklerose - Google Patents

Optisk avbildning av sårbar arteriosklerose

Info

Publication number
NO20035748D0
NO20035748D0 NO20035748A NO20035748A NO20035748D0 NO 20035748 D0 NO20035748 D0 NO 20035748D0 NO 20035748 A NO20035748 A NO 20035748A NO 20035748 A NO20035748 A NO 20035748A NO 20035748 D0 NO20035748 D0 NO 20035748D0
Authority
NO
Norway
Prior art keywords
arteriosclerosis
vulnerable
optical imaging
imaging
optical
Prior art date
Application number
NO20035748A
Other languages
English (en)
Norwegian (no)
Inventor
Jo Klaveness
Edvin Johannesen
Helge Tolleshaug
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20035748A priority Critical patent/NO20035748D0/no
Publication of NO20035748D0 publication Critical patent/NO20035748D0/no
Priority to US10/582,680 priority patent/US20080019907A1/en
Priority to PCT/NO2004/000395 priority patent/WO2005058153A2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20035748A 2003-12-19 2003-12-19 Optisk avbildning av sårbar arteriosklerose NO20035748D0 (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO20035748A NO20035748D0 (no) 2003-12-19 2003-12-19 Optisk avbildning av sårbar arteriosklerose
US10/582,680 US20080019907A1 (en) 2003-12-19 2004-12-17 Optical Imaging Contrast Agents
PCT/NO2004/000395 WO2005058153A2 (fr) 2003-12-19 2004-12-17 Agents de contraste d'imagerie optique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20035748A NO20035748D0 (no) 2003-12-19 2003-12-19 Optisk avbildning av sårbar arteriosklerose

Publications (1)

Publication Number Publication Date
NO20035748D0 true NO20035748D0 (no) 2003-12-19

Family

ID=31885181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035748A NO20035748D0 (no) 2003-12-19 2003-12-19 Optisk avbildning av sårbar arteriosklerose

Country Status (3)

Country Link
US (1) US20080019907A1 (fr)
NO (1) NO20035748D0 (fr)
WO (1) WO2005058153A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006102395A2 (fr) * 2005-03-22 2006-09-28 Medstar Health Inc Systemes et methodes d'administration pour le diagnostic et le traitement de maladies cardio-vasculaires
US8440167B2 (en) * 2008-10-27 2013-05-14 University Of Virginia Patent Foundation Multimodal imaging of atherosclerotic plaque targeted to LOX-1
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
WO2013070688A1 (fr) 2011-11-11 2013-05-16 Yale University Reprogrammation de l'urokinase en un agent anticancéreux de recrutement d'anticorps
CN113797358A (zh) * 2020-06-16 2021-12-17 四川大学华西医院 一种双靶向双模态显影纳米粒及其制备方法
RU2756422C1 (ru) * 2020-06-29 2021-09-30 федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет им. И.И. Мечникова" Министерства здравоохранения Российской Федерации Способ выбора тактики хирургического лечения больных с облитерирующим атеросклерозом артерий нижних конечностей

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
HUP0105284A3 (en) * 1999-02-19 2003-12-29 Zymogenetics Inc Seattle Inhibitors for use in hemostasis and immune function
EP1283728A2 (fr) * 2000-05-23 2003-02-19 Amersham Health AS Agents de contraste
EP1289565B1 (fr) * 2000-06-02 2015-04-22 Bracco Suisse SA Composes pour le ciblage des cellules endotheliales
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US6615063B1 (en) * 2000-11-27 2003-09-02 The General Hospital Corporation Fluorescence-mediated molecular tomography
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
US7439319B2 (en) * 2001-09-14 2008-10-21 Burnham Institute For Medical Research Selective substrates for matrix metalloproteinases
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
NO20034351D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av endometrose
US20050089470A1 (en) * 2003-10-24 2005-04-28 Johnson Bruce F. Labeled peptides for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
NO20035682D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av ösofagkreft og Barretts ösofag
NO20035681D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft

Also Published As

Publication number Publication date
US20080019907A1 (en) 2008-01-24
WO2005058153A3 (fr) 2006-04-27
WO2005058153A2 (fr) 2005-06-30

Similar Documents

Publication Publication Date Title
FI20030326A0 (fi) Datan syöttö
HK1083060A1 (en) Characterization of arteriosclerosis by optical imaging
DK1675501T3 (da) Ikke-invasiv optisk monitorering af et område af interesse
DE602005006458D1 (de) Abbildungslinse
DE112005003698A5 (de) Erfassung optischer Strahlung
DE602004030576D1 (de) Optisches aufzeichnungsverfahren
DE502004001561D1 (de) Kamera
NO20062387L (no) Novel imaging agents
NO20054188D0 (no) Et arrangement av fagverksstag
DE602004015991D1 (de) Optische bilder-einrichtung
NO20035681D0 (no) Optisk avbildning av lungekreft
SE0302837L (sv) Användning av IR-kamera
DE602004026172D1 (de) Optischer detektor der enzymaktivierung
FR2840796B1 (fr) Obturateur bronchique
FR2863472B1 (fr) Endoscope
DE60301365D1 (de) Optischer Verschiebungsdetektor
DE50311591D1 (de) Optischer sensor
DE602004019259D1 (de) Optischer Kollimator
NO20034350D0 (no) Optisk avbilding av kolorektal kreft
NO20035683D0 (no) Optisk avbildning av prostatakreft
DE60336077D1 (de) Optischer sensor
DE602004000502D1 (de) Optischer Breitbandverstärker
NO20044016L (no) Fremgangsmate for nedad-ekstrapolering av seismiske data
NO20035748D0 (no) Optisk avbildning av sårbar arteriosklerose
DE60304800D1 (de) Optischer Verstärker